Cargando…
Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization
PURPOSE: The current investigation is on the explicit development and evaluation of nanostructured lipidic carriers (NLCs) through the oral route to overcome the inherent lacuna of chemotherapeutic drug, in which Ribociclib (RBO) was used for breast cancer to diminish the bioavailability issue. METH...
Autores principales: | Sartaj, Ali, Annu, Biswas, Largee, Verma, Anita Kamra, Sahoo, P. K., Baboota, Sanjula, Ali, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831049/ https://www.ncbi.nlm.nih.gov/pubmed/35155677 http://dx.doi.org/10.1155/2022/6009309 |
Ejemplares similares
-
Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer
por: Shrivastava, Nupur, et al.
Publicado: (2022) -
An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor
por: Annu,, et al.
Publicado: (2022) -
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
por: Khan, Saba, et al.
Publicado: (2015) -
Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression
por: Qizilbash, Farheen Fatima, et al.
Publicado: (2022) -
Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations
por: Sartaj, Ali, et al.
Publicado: (2021)